Didem Sözütek1, Serdar Yanık2, Ayşe Neslin Akkoca3, Alper Sözütek4, Zeynep Tuba Ozdemir5, Ciğdem Usul Avşar6, Meral Günaldı7, Berksoy Sahin8, Figen Doron9. 1. Department of Internal Medicine, Iskenderun State Hospital Hatay, Turkey. 2. Department of Patology, Iskenderun State Hospital Hatay, Turkey. 3. Department of Family Medicine, Iskenderun State Hospital Hatay, Turkey. 4. Department of General Surgeons and Gastroenterology, Mersin State Hospital Mersin, Turkey. 5. Department of Internal Medicine, Bozok University Medical School Yozgat, Turkey. 6. Department of Medical Oncology, Çorlu Statae Hospital Tekirdağ, Turkey. 7. Department of Medical Oncology Dr. Sadi Konuk Research Hospital İstanbul, Turkey. 8. Department of Medical Oncology, Cukurova University Medical School, Internal Medicine Adana, Turkey. 9. Department of Patology, Cukurova University Medical School Adana, Turkey.
Abstract
AIM: Gastrointestinal stromal tumor is the most common mesenchymal neoplasia in the gastrointestinal tract and has a broad spectrum of pathological patterns and also clinical features changing from benign to malignant. Although the well-characterized parameters to predict the outcome have been the size and the mitotic index of the tumor in the patients with early-staged disease, bulky recurrent or metastatic tumor, resistance to medical treatment and mutation analysis are the prognostic factors for advanced stage-GIST. The aim of this study is to investigate new and more practical tissue markers, such as DOG1 and Ki-67 to specify the GIST diagnosis and also to predict the outcome in GIST patients with both localized and advanced staged disease. METHODS: For the last 14 years, from 1999 to 2013, 111 patients with a histopathological GIST diagnosis from the hospital files were enrolled to the study. In their parafin-embedded tissue samples, DOG1 and Ki-67 expressions were evaluated with immunohistochemisty by two independent pathologists from Cukurova University Medical Faculty. Patients were divided into two groups, the patients with localized disease treated by surgery and the patients with advanced/metastatic disease. DOG1 and Ki-67 expressions were corelated with other diagnostic and prognostic histopathological markers and also the clinical outcome in these two group of patients. RESULTS: The specificity and the sensitivity of DOG1 in GIST diagnosis was found 94 and 43%, respectively. DOG1 expression was especially important in the diagnosis of c-kit negative cases. Although Ki-67 was not found a statistically significant prognostic factor for overall survival, it was strongly corelated with mitotic index which is a well-known standart prognostic factor for localized disease. DISCUSSION: DOG1 seems to be an important diagnostic tool for clinically suspected GIST diagnosis in both advanced or early staged patients whose tumours are c-kit expression negative. On the other hand, Ki-67 can be a stronger candidate for prognostic factor instead of mitotic index to identify the proliferative cells out of mitotic phase but this statement needs be prospectively validated on studies with large number of patients.
AIM: Gastrointestinal stromal tumor is the most common mesenchymal neoplasia in the gastrointestinal tract and has a broad spectrum of pathological patterns and also clinical features changing from benign to malignant. Although the well-characterized parameters to predict the outcome have been the size and the mitotic index of the tumor in the patients with early-staged disease, bulky recurrent or metastatic tumor, resistance to medical treatment and mutation analysis are the prognostic factors for advanced stage-GIST. The aim of this study is to investigate new and more practical tissue markers, such as DOG1 and Ki-67 to specify the GIST diagnosis and also to predict the outcome in GIST patients with both localized and advanced staged disease. METHODS: For the last 14 years, from 1999 to 2013, 111 patients with a histopathological GIST diagnosis from the hospital files were enrolled to the study. In their parafin-embedded tissue samples, DOG1 and Ki-67 expressions were evaluated with immunohistochemisty by two independent pathologists from Cukurova University Medical Faculty. Patients were divided into two groups, the patients with localized disease treated by surgery and the patients with advanced/metastatic disease. DOG1 and Ki-67 expressions were corelated with other diagnostic and prognostic histopathological markers and also the clinical outcome in these two group of patients. RESULTS: The specificity and the sensitivity of DOG1 in GIST diagnosis was found 94 and 43%, respectively. DOG1 expression was especially important in the diagnosis of c-kit negative cases. Although Ki-67 was not found a statistically significant prognostic factor for overall survival, it was strongly corelated with mitotic index which is a well-known standart prognostic factor for localized disease. DISCUSSION: DOG1 seems to be an important diagnostic tool for clinically suspected GIST diagnosis in both advanced or early staged patients whose tumours are c-kit expression negative. On the other hand, Ki-67 can be a stronger candidate for prognostic factor instead of mitotic index to identify the proliferative cells out of mitotic phase but this statement needs be prospectively validated on studies with large number of patients.
Authors: S Sakurai; M Fukayama; Y Kaizaki; K Saito; K Kanazawa; M Kitamura; Y Iwasaki; T Hishima; Y Hayashi; M Koike Journal: Cancer Date: 1998-11-15 Impact factor: 6.860
Authors: Wei-Lien Wang; Jason L Hornick; Raj Mallipeddi; Bettina G Zelger; Joshua D Rother; Dan Yang; Dina C Lev; Jonathan C Trent; Victor G Prieto; Thomas Brenn; Alistair Robson; Eduardo Calonje; Alexander J F Lazar Journal: Am J Dermatopathol Date: 2009-05 Impact factor: 1.533
Authors: Ronald P Dematteo; Jason S Gold; Lisa Saran; Mithat Gönen; Kui Hin Liau; Robert G Maki; Samuel Singer; Peter Besmer; Murray F Brennan; Cristina R Antonescu Journal: Cancer Date: 2008-02-01 Impact factor: 6.860
Authors: Jong Kyung Park; Seung Hye Choi; Seong Lee; Ki Ouk Min; Sang Seob Yun; Hae Myung Jeon Journal: J Korean Med Sci Date: 2004-10 Impact factor: 2.153
Authors: Safinur Atay; Daniel W Wilkey; Mohammed Milhem; Michael Merchant; Andrew K Godwin Journal: Mol Cell Proteomics Date: 2017-12-14 Impact factor: 5.911